ペプチドリームの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/05/16 | 5,590 | 5,710 | 5,560 | 5,660 | +100 | +1.8% | 818,800 |
2019/05/15 | 5,740 | 5,740 | 5,560 | 5,560 | -10 | -0.2% | 1,007,900 |
2019/05/14 | 5,580 | 5,680 | 5,510 | 5,570 | -110 | -1.9% | 1,609,700 |
2019/05/13 | 5,890 | 5,900 | 5,680 | 5,680 | -170 | -2.9% | 1,203,500 |
2019/05/10 | 5,800 | 6,020 | 5,780 | 5,850 | -50 | -0.8% | 934,100 |
2019/05/09 | 6,080 | 6,120 | 5,850 | 5,900 | -180 | -3% | 988,300 |
2019/05/08 | 6,100 | 6,100 | 6,040 | 6,080 | -60 | -1% | 624,900 |
2019/05/07 | 6,060 | 6,200 | 6,030 | 6,140 | +150 | +2.5% | 816,000 |
2019/04/26 | 5,950 | 6,010 | 5,890 | 5,990 | +40 | +0.7% | 632,500 |
2019/04/25 | 5,970 | 6,010 | 5,920 | 5,950 | +30 | +0.5% | 514,700 |
2019/04/24 | 5,980 | 6,060 | 5,870 | 5,920 | +40 | +0.7% | 997,800 |
2019/04/23 | 5,850 | 5,890 | 5,730 | 5,880 | -90 | -1.5% | 852,900 |
2019/04/22 | 5,990 | 6,070 | 5,920 | 5,970 | +20 | +0.3% | 720,100 |
2019/04/19 | 5,850 | 5,950 | 5,820 | 5,950 | +160 | +2.8% | 716,900 |
2019/04/18 | 5,890 | 5,900 | 5,780 | 5,790 | -150 | -2.5% | 706,000 |
2019/04/17 | 5,860 | 5,940 | 5,850 | 5,940 | +70 | +1.2% | 681,800 |
2019/04/16 | 5,850 | 5,920 | 5,790 | 5,870 | +80 | +1.4% | 867,100 |
2019/04/15 | 5,760 | 5,870 | 5,750 | 5,790 | +100 | +1.8% | 851,800 |
2019/04/12 | 5,640 | 5,710 | 5,480 | 5,690 | +30 | +0.5% | 1,108,400 |
2019/04/11 | 5,700 | 5,880 | 5,650 | 5,660 | +20 | +0.4% | 1,707,600 |
2019/04/10 | 5,490 | 5,690 | 5,470 | 5,640 | +50 | +0.9% | 1,135,500 |
2019/04/09 | 5,440 | 5,600 | 5,390 | 5,590 | +180 | +3.3% | 1,028,900 |
2019/04/08 | 5,320 | 5,440 | 5,310 | 5,410 | +90 | +1.7% | 548,400 |
2019/04/05 | 5,280 | 5,340 | 5,250 | 5,320 | +20 | +0.4% | 524,400 |
2019/04/04 | 5,300 | 5,360 | 5,280 | 5,300 | -20 | -0.4% | 652,700 |
2019/04/03 | 5,220 | 5,360 | 5,210 | 5,320 | +120 | +2.3% | 678,400 |
2019/04/02 | 5,420 | 5,420 | 5,140 | 5,200 | -180 | -3.3% | 1,009,300 |
2019/04/01 | 5,500 | 5,530 | 5,380 | 5,380 | -50 | -0.9% | 946,600 |
2019/03/29 | 5,400 | 5,440 | 5,350 | 5,430 | +40 | +0.7% | 577,200 |
2019/03/28 | 5,210 | 5,430 | 5,180 | 5,390 | +150 | +2.9% | 970,100 |
2019/03/27 | 5,310 | 5,400 | 5,230 | 5,240 | -70 | -1.3% | 1,076,600 |
2019/03/26 | 5,310 | 5,380 | 5,290 | 5,310 | +40 | +0.8% | 923,800 |
2019/03/25 | 5,200 | 5,280 | 5,170 | 5,270 | -80 | -1.5% | 650,300 |
2019/03/22 | 5,350 | 5,380 | 5,310 | 5,350 | -50 | -0.9% | 481,800 |
2019/03/20 | 5,380 | 5,400 | 5,330 | 5,400 | -10 | -0.2% | 405,600 |
2019/03/19 | 5,440 | 5,440 | 5,340 | 5,410 | -60 | -1.1% | 438,500 |
2019/03/18 | 5,490 | 5,520 | 5,410 | 5,470 | +30 | +0.6% | 491,900 |
2019/03/15 | 5,420 | 5,470 | 5,370 | 5,440 | +80 | +1.5% | 605,000 |
2019/03/14 | 5,480 | 5,480 | 5,340 | 5,360 | -80 | -1.5% | 478,800 |
2019/03/13 | 5,450 | 5,460 | 5,370 | 5,440 | ±0 | ±0% | 383,800 |
2019/03/12 | 5,390 | 5,480 | 5,370 | 5,440 | +110 | +2.1% | 628,800 |
2019/03/11 | 5,370 | 5,390 | 5,270 | 5,330 | ±0 | ±0% | 590,500 |
2019/03/08 | 5,320 | 5,350 | 5,270 | 5,330 | -90 | -1.7% | 762,200 |
2019/03/07 | 5,470 | 5,510 | 5,380 | 5,420 | -110 | -2% | 833,300 |
2019/03/06 | 5,460 | 5,560 | 5,460 | 5,530 | +50 | +0.9% | 889,300 |
2019/03/05 | 5,400 | 5,480 | 5,360 | 5,480 | +30 | +0.6% | 478,900 |
2019/03/04 | 5,490 | 5,520 | 5,410 | 5,450 | +20 | +0.4% | 705,200 |
2019/03/01 | 5,320 | 5,470 | 5,320 | 5,430 | +140 | +2.6% | 822,200 |
2019/02/28 | 5,270 | 5,300 | 5,210 | 5,290 | +20 | +0.4% | 577,900 |
2019/02/27 | 5,150 | 5,350 | 5,130 | 5,270 | +160 | +3.1% | 862,200 |
1451~
1500
件表示中 / 2899件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ペプチド | 187,900円 | +5.0% | +1.5% | 0.00% | 16.13倍 | 4.29倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 358,900円 | +7.9% | +8.9% | 3.46% | 7.68倍 | 1.03倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
住友ファーマ | 62,300円 | +21.1% | - | 0.00% | 15.47倍 | 2.17倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
科研薬 | 415,900円 | +30.5% | +111.0% | 4.57% | 11.72倍 | 1.02倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 381,500円 | +14.5% | -2.3% | 2.36% | 13.96倍 | 0.75倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム